(Q39035462)

8 September 2017

1 reference

title

Tau Positron Emission Tomography Imaging (English)

1 reference

positron emission tomography

8 September 2017

main subject

1 reference

Hartmuth C Kolb

1

1 reference

8 September 2017

José Ignacio Andrés

series ordinal

2

1 reference

8 September 2017

publication date

9 December 2016

1 reference

Cold Spring Harbor Perspectives in Biology

8 September 2017

published in

1 reference

8 September 2017

volume

9

1 reference

8 September 2017

issue

5

1 reference

Therapeutics of Alzheimer's disease: Past, present and future

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Myelin architecture: zippering membranes tightly together

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Alzheimer's disease: strategies for disease modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Intercellular transfer of tau aggregates and spreading of tau pathology: Implications for therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

2014 Alzheimer's disease facts and figures

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Use of a benzimidazole derivative BF-188 in fluorescence multispectral imaging for selective visualization of tau protein fibrils in the Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of 11C-PBB3 as a clinically useful PET probe for imaging of tau pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Alternative approaches for PET radiotracer development in Alzheimer's disease: imaging beyond plaque.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Differentiating Alzheimer disease-associated aggregates with small molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Phylogenetic diversity of the expression of the microtubule-associated protein tau: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Lessons from tau-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

The β-Amyloid Hypothesis in Alzheimer's Disease: Seeing Is Believing

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Towards a Pharmacophore for Amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

The Revitalized Tau Hypothesis on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

New targets for the development of PET tracers for imaging neurodegeneration in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Positron emission tomography radioligands for in vivo imaging of Aβ plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

(18)F-labeled phenyldiazenyl benzothiazole for in vivo imaging of neurofibrillary tangles in Alzheimer's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

The role of tau in Alzheimer's disease and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Positron emission tomography of brain β-amyloid and τ levels in adults with Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

The benzazole scaffold: a SWAT to combat Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Tau PET imaging in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Positron emission tomography in CNS drug discovery and drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Mechanistic studies unravel the complexity inherent in tau aggregation leading to Alzheimer's disease and the tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Brain imaging in the study of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Amyloid imaging with PET in early Alzheimer disease diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Molecular Imaging Insights into Neurodegeneration: Focus on Tau PET Radiotracers

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

PET of brain amyloid and tau in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

PET Scanning of Brain Tau in Retired National Football League Players: Preliminary Findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Tau pathology and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Strategies for improving the postmortem neuropathological diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

In vivo tau imaging: obstacles and progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Tau imaging: early progress and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Human Tau isoforms assemble into ribbon-like fibrils that display polymorphic structure and stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

[(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

A highly selective and specific PET tracer for imaging of tau pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Advances of molecular imaging probes for the diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Developments in Tau PET Imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A023721

Positron emission tomography molecular imaging for drug development

21 January 2018

1 reference

12 December 2020

N'-benzylidene-benzohydrazides as novel and selective tau-PHF ligands.

1 reference

12 December 2020

The merits of FDDNP-PET imaging in Alzheimer's disease

1 reference

12 December 2020

Imidazo[2,1]thiazol-3-one Derivatives Useful as Diagnostic Agents for Alzheimer's Disease

1 reference

12 December 2020

Landscapes of four-enantiomer conical intersections for photoisomerization of stilbene: CASSCF calculation

1 reference

12 December 2020

Diagnosis of Alzheimer's disease

1 reference

12 December 2020

[Diagnosis of Alzheimer's disease]

1 reference

12 December 2020

10.1101/CSHPERSPECT.A023721

Identifiers

DOI

1 reference

8 September 2017

0 references

1 reference